Huxley Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and commercial release of central sleep apnea (CSA) detection for its SANSA(R) home sleep apnea test.

Huxley Medical, Inc. announced the SANSA(R) home sleep apnea test has received regulatory clearance from the United States Food and Drug Administration (FDA) to be used as a diagnostic ECG monitor, ...

With a career in helping Paducah residents find better sleep, one local surgeon is recognized for his work treating ...

Audrey Stetson and John Redfield stop by Rest Up Sleep Solutions in Escanaba to learn about dental appliances that can ...

Older adults with a combination of insomnia and obstructive sleep apnea demonstrated worse sleep and verbal memory ...

Narcolepsy can be described as a neurological condition that has chronic consequences on the regulation of the sleep-wake ...

Compared with the outpatient setting, there is a lack of guidance on diagnosing, managing and treating obstructive sleep ...

Quality improvement programs markedly increase sleep apnea testing in stroke patients, showing effective ways to improve guideline-based care. A structured quality improvement (QI) program led to a ...

Vivos Eyes High Growth Potential from Commercial Affiliation with Prominent Auburn Hills, Michigan Sleep Practice MISleep SolutionsLITTLETON, Colo., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Vivos ...

Your pillow is one of the most powerful tools to help you fall asleep, stay asleep—and even ease your pain and improve ...

Find out more about how routine ECGs and AI help detect liver cirrhosis earlier in primary care. Learn more about the ...

Discusses Strategic Business Model Pivot and Transition in Sleep Apnea Treatment Approach December 16, 2025 11:00 ...